Follicle-Stimulating Hormone

Follicle-stimulating hormone (FSH) is a glycoprotein hormone produced by the anterior pituitary gland, primarily involved in regulating reproductive processes in both females and males. Researchers primarily study FSH for its critical role in folliculogenesis and spermatogenesis, as well as its emerging functions in extragonadal tissues. Key findings indicate that FSH regulates granulosa cell glutamine synthesis to influence ovulation and plays a significant role in orchestrating insulin secretion in pancreatic islet cells. Additionally, studies suggest that FSH may have broader implications beyond reproduction, potentially affecting bone health, obesity, and cardiovascular risk. Current research continues to explore the multifaceted roles of FSH, highlighting its clinical relevance in fertility treatments and metabolic health.

Follicle-Stimulating Hormone (FSH) is an endogenous glycoprotein hormone produced by the anterior pituitary gland. It belongs to the pituitary and trophic hormones category and plays a crucial role in the reproductive systems of both males and females. FSH is also available in synthetic forms, such as Gonal-F and Follistim, used in clinical settings. Researchers have observed that FSH is primarily involved in regulating reproductive processes, including the development of ovarian follicles in females and spermatogenesis in males. Recent studies have expanded its known roles beyond reproduction, indicating its involvement in metabolic processes, such as insulin secretion in pancreatic islets, and potential implications in conditions like polycystic ovary syndrome (PCOS) and postmenopausal diabetes. The mechanism of action of FSH involves binding to the follicle-stimulating hormone receptor (FSHR), which activates downstream signaling pathways, including the cAMP/protein kinase A (PKA) and calcium pathways. These pathways are crucial for its role in reproductive and metabolic functions. Pharmacokinetic properties of FSH indicate that its circulating half-life is approximately 3-4 hours. It is primarily metabolized by the liver and kidneys, with bioavailability varying based on the route of administration. Clinically, FSH is used in assisted reproductive technologies to stimulate follicular growth and is being explored for its therapeutic potential in male infertility. It is a prescription-only medication, regulated by health authorities in various countries.

FSH acts on the follicle-stimulating hormone receptor (FSHR), primarily activating the Gαs protein, which in turn stimulates the cAMP/protein kinase A (PKA) and calcium signaling pathways. This cascade is essential for its role in follicular development and spermatogenesis, as well as glucose-stimulated insulin secretion in pancreatic islets.

Follicle-stimulating hormone (FSH) exerts its effects primarily through binding to the follicle-stimulating hormone receptor (FSHR), which activates the Gαs signaling pathway, leading to increased cAMP levels and subsequent activation of the cAMP/protein kinase A (PKA) pathway. This signaling cascade promotes granulosa cell glutamine synthesis, inhibits apoptosis via the ASK1-JNK apoptotic pathway, and orchestrates glucose-stimulated insulin secretion in pancreatic islet β-cells. Additionally, FSH's role in spermatogenesis involves signaling in Sertoli cells, although the precise mechanisms in male fertility remain less well-defined.

Current evidence is limited regarding the precise mechanisms by which FSH influences spermatogenesis in men, particularly in those with idiopathic infertility or normal FSH levels but impaired sperm production. Further research is needed through well-controlled, larger randomized controlled trials (RCTs) to evaluate the therapeutic benefits of FSH administration in various male populations, including those with hypogonadotropic hypogonadism. Additionally, the role of FSH in extragonadal tissues, such as its impact on metabolic disorders and bone health, requires further exploration to clarify its broader physiological implications and potential therapeutic targets.